#Repaglinide (#C27H36N2O4) is a #pharmaceutical agent employed to manage type 2 diabetes mellitus by stimulating insulin release. Its structure features a carbonyl group (-CO) attached to a piperidine ring, with sp3 hybridization in the carbon atoms of the piperidine ring and sp2 hybridization in the carbonyl carbon.